XML 45 R34.htm IDEA: XBRL DOCUMENT v3.22.0.1
Business Segment Information Business Segment Information (Tables)
9 Months Ended
Dec. 31, 2021
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
Financial information for each of our segments is presented in the following table:
 Three Months Ended December 31, Nine Months Ended December 31,
 2021202020212020
Revenues:(*as adjusted)(*as adjusted)
Healthcare $759,675 $521,662 $2,106,626 $1,392,247 
Applied Sterilization Technologies216,298 176,462 630,092 498,371 
Life Sciences127,908 110,800 381,706 343,370 
Dental105,090 — 255,954 — 
Total revenues$1,208,971 $808,924 $3,374,378 $2,233,988 
Operating income (loss):
Healthcare$169,267 $115,412 $465,817 $304,380 
Applied Sterilization Technologies101,343 81,626 303,059 222,416 
Life Sciences52,032 41,541 158,639 136,435 
Dental23,096 — 65,607 — 
Corporate(55,849)(47,941)(202,461)(158,463)
Total operating income before adjustments$289,889 $190,638 $790,661 $504,768 
Less: Adjustments
Amortization of acquired intangible assets (1)
$75,021 $23,194 $191,552 $62,648 
Acquisition and integration related charges (2)
9,298 11,563 167,698 13,984 
Redomiciliation and tax restructuring costs (3)
118 296 228 850 
(Gain) on fair value adjustment of acquisition related contingent consideration (1)
 (500) (500)
Net loss on divestiture of businesses (1)
489 — 893 
Amortization of inventory and property "step up" to fair value (1)
2,237 1,784 96,513 3,101 
COVID-19 incremental costs (4)
 7,251  20,460 
Restructuring (credit) charges (5)
(207)20 17 110 
Total operating income$202,933 $147,030 $333,760 $404,110 
Revenue from External Customers by Products and Services [Table Text Block]
 Three Months Ended December 31, Nine Months Ended December 31,
 2021202020212020
Healthcare:
Capital equipment$217,214 $147,855 $570,509 $407,610 
Consumables273,750 148,839 750,531 355,390
Service268,711 224,968 785,586 629,247 
Total Healthcare Revenues $759,675 $521,662 $2,106,626 $1,392,247 
Applied Sterilization Technologies Service Revenues$216,298 $176,462 $630,092 $498,371 
Life Sciences:
Capital equipment
$30,412 $28,993 $97,343 $88,664 
Consumables61,096 49,627 179,380 164,262 
Service36,400 32,180 104,983 90,444 
Total Life Sciences Revenues$127,908 $110,800 $381,706 $343,370 
Dental Revenues$105,090 $— $255,954 $— 
Total Revenues$1,208,971 $808,924 $3,374,378 $2,233,988 
Revenue from External Customers by Geographic Areas [Table Text Block]
Three Months Ended December 31, Nine Months Ended December 31,
2021202020212020
Revenues:
Ireland$20,086 $20,316 $62,077 $51,779 
United States851,292 572,397 2,383,039 1,613,554 
Other locations337,593 216,211 929,262 568,655 
Total Revenues
$1,208,971 $808,924 $3,374,378 $2,233,988 
December 31, 2021March 31, 2021
Property, Plant, and Equipment, Net
Ireland$54,977 $52,140 
United States859,601 673,784 
Other locations607,009 509,476 
Property, Plant, and Equipment, Net$1,521,587 $1,235,400 
Reconciliation of Assets from Segment to Consolidated Assets include the current and long-lived assets directly attributable to the segment based on the management of the location or on utilization. Certain corporate assets were allocated to the reportable segments based on revenues. Assets attributed to sales and distribution locations are only allocated to the Healthcare and Life Sciences segments.
Individual facilities, equipment, and intellectual properties are utilized for production by both the Healthcare and Life Sciences segments at varying levels over time. As a result, an allocation of total assets, capital expenditures, and depreciation and amortization is not meaningful to the individual performance of the Healthcare and Life Sciences segments. Therefore, their respective amounts are reported together.
December 31, 2021March 31, 2021
Assets:
Healthcare and Life Sciences$5,374,009 $3,600,182 
Applied Sterilization Technologies3,047,602 2,974,289 
Dental1,118,528 — 
Cantel related goodwill not yet allocated (1)
2,149,827 — 
Total assets
$11,689,966 $6,574,471